Cargando…

Altered Chromogranin A Circulating Levels in Meniere's Disease

Objectives. Meniere's disease (MD) is an inner ear disorder characterized by episodic vertigo, ear fullness, and hearing loss; usually vertigo attacks cluster in specific period. We studied in MD patients the circulating levels of chromogranin A (CgA) and vasostatin-1 (VS-1), secreted by the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Teggi, Roberto, Colombo, Barbara, Trimarchi, Matteo, Bianco, Mimma, Manfredi, Angelo, Bussi, Mario, Corti, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423029/
https://www.ncbi.nlm.nih.gov/pubmed/25983374
http://dx.doi.org/10.1155/2015/643420
_version_ 1782370142041145344
author Teggi, Roberto
Colombo, Barbara
Trimarchi, Matteo
Bianco, Mimma
Manfredi, Angelo
Bussi, Mario
Corti, Angelo
author_facet Teggi, Roberto
Colombo, Barbara
Trimarchi, Matteo
Bianco, Mimma
Manfredi, Angelo
Bussi, Mario
Corti, Angelo
author_sort Teggi, Roberto
collection PubMed
description Objectives. Meniere's disease (MD) is an inner ear disorder characterized by episodic vertigo, ear fullness, and hearing loss; usually vertigo attacks cluster in specific period. We studied in MD patients the circulating levels of chromogranin A (CgA) and vasostatin-1 (VS-1), secreted by the neuroendocrine system and involved in the regulation of the endothelial barrier function. Methods. Serum levels were assessed in 37 MD patients and 36 controls. The ratio between VS-1 and CgA was calculated. Results. CgA was increased in patients compared to controls (1.46 versus 0.67 nM, p = 0.01) while no difference was detected for VS-1 (0.41 versus 0.39, resp.). CgA levels in patients positively correlated with the frequency of vertigo spells in the previous four weeks (p = 0.008) and negatively with the time in days from the last vertigo attack (p = 0.018). Furthermore, the VS-1/CgA ratio negatively correlated with the frequency of vertigo spells (p = 0.029) and positively correlated with the time from the last attack (p = 0.003). Conclusion. The results indicate that variations of CgA levels, but not of VS-1, occur in the blood of patients with active MD, depending on the frequency of vertigo spells and the time from the last crisis.
format Online
Article
Text
id pubmed-4423029
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44230292015-05-17 Altered Chromogranin A Circulating Levels in Meniere's Disease Teggi, Roberto Colombo, Barbara Trimarchi, Matteo Bianco, Mimma Manfredi, Angelo Bussi, Mario Corti, Angelo Dis Markers Research Article Objectives. Meniere's disease (MD) is an inner ear disorder characterized by episodic vertigo, ear fullness, and hearing loss; usually vertigo attacks cluster in specific period. We studied in MD patients the circulating levels of chromogranin A (CgA) and vasostatin-1 (VS-1), secreted by the neuroendocrine system and involved in the regulation of the endothelial barrier function. Methods. Serum levels were assessed in 37 MD patients and 36 controls. The ratio between VS-1 and CgA was calculated. Results. CgA was increased in patients compared to controls (1.46 versus 0.67 nM, p = 0.01) while no difference was detected for VS-1 (0.41 versus 0.39, resp.). CgA levels in patients positively correlated with the frequency of vertigo spells in the previous four weeks (p = 0.008) and negatively with the time in days from the last vertigo attack (p = 0.018). Furthermore, the VS-1/CgA ratio negatively correlated with the frequency of vertigo spells (p = 0.029) and positively correlated with the time from the last attack (p = 0.003). Conclusion. The results indicate that variations of CgA levels, but not of VS-1, occur in the blood of patients with active MD, depending on the frequency of vertigo spells and the time from the last crisis. Hindawi Publishing Corporation 2015 2015-04-23 /pmc/articles/PMC4423029/ /pubmed/25983374 http://dx.doi.org/10.1155/2015/643420 Text en Copyright © 2015 Roberto Teggi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Teggi, Roberto
Colombo, Barbara
Trimarchi, Matteo
Bianco, Mimma
Manfredi, Angelo
Bussi, Mario
Corti, Angelo
Altered Chromogranin A Circulating Levels in Meniere's Disease
title Altered Chromogranin A Circulating Levels in Meniere's Disease
title_full Altered Chromogranin A Circulating Levels in Meniere's Disease
title_fullStr Altered Chromogranin A Circulating Levels in Meniere's Disease
title_full_unstemmed Altered Chromogranin A Circulating Levels in Meniere's Disease
title_short Altered Chromogranin A Circulating Levels in Meniere's Disease
title_sort altered chromogranin a circulating levels in meniere's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423029/
https://www.ncbi.nlm.nih.gov/pubmed/25983374
http://dx.doi.org/10.1155/2015/643420
work_keys_str_mv AT teggiroberto alteredchromograninacirculatinglevelsinmenieresdisease
AT colombobarbara alteredchromograninacirculatinglevelsinmenieresdisease
AT trimarchimatteo alteredchromograninacirculatinglevelsinmenieresdisease
AT biancomimma alteredchromograninacirculatinglevelsinmenieresdisease
AT manfrediangelo alteredchromograninacirculatinglevelsinmenieresdisease
AT bussimario alteredchromograninacirculatinglevelsinmenieresdisease
AT cortiangelo alteredchromograninacirculatinglevelsinmenieresdisease